Search

everythinglearnresearchcommunity

for

Search:↓

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

New technologies help better understand and treat inflammatory skin diseases.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New therapies for rare skin diseases show promise but need more research.

Histone modification is key in treating chronic inflammatory skin diseases.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Chicken feather gene mutation helps understand human hair disorders.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Fzd2 is important for skin and hair development through various signaling ways.

The study suggests that hypothyroidism may cause alopecia areata.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.